Fowl Cholera in Poultry: Etiology, Clinical Signs, and Control
Introduction
Fowl cholera, also termed avian pasteurellosis or avian cholera, is a contagious bacterial disease affecting domestic poultry, waterfowl, and numerous wild bird species. The disease is caused by the gram-negative coccobacillus Pasteurella multocida. Fowl cholera remains a significant cause of morbidity, mortality, and economic loss in commercial poultry operations worldwide. This article provides a comprehensive review of the etiology, clinical signs, pathology, diagnostics, treatment, and control measures for fowl cholera in poultry, with specific attention to the disease in broiler flocks and its presentation across different avian hosts.
Etiology
Pasteurella multocida is a nonmotile, facultatively anaerobic, gram-negative bacterium belonging to the family Pasteurellaceae. The organism exhibits bipolar staining when treated with methylene blue or Wright stain, a characteristic that aids in preliminary microscopic identification. P. multocida is classified into five capsular serogroups (A, B, D, E, F) based on capsular antigens and into 16 somatic serotypes (1 through 16) based on lipopolysaccharide antigens. The primary serotypes associated with fowl cholera in poultry are A:1, A:3, A:4, and A:3,4. Serotype A:1 is frequently isolated from acute outbreaks in chickens and turkeys, while serotype A:3 is more commonly associated with chronic forms of the disease.
The bacterium possesses multiple virulence factors that facilitate host colonization and disease pathogenesis. Capsular polysaccharide protects the organism from phagocytosis and complement-mediated killing. Lipopolysaccharide (endotoxin) contributes to the systemic inflammatory response and septic shock observed in acute infections. Outer membrane proteins, fimbriae, and a siderophore-dependent iron acquisition system enable adherence to respiratory epithelium and nutrient acquisition within the host. P. multocida also produces a dermonecrotic toxin, which is a potent mitogen that stimulates osteoclastic bone resorption and contributes to the turbinate atrophy observed in some mammalian hosts.
Transmission occurs primarily via direct contact between infected and susceptible birds, through respiratory aerosols, and by contamination of feed, water, and environmental fomites. Chronically infected carriers and asymptomatic birds serve as reservoirs, intermittently shedding the organism in nasal and oral secretions. The incubation period typically ranges from 3 to 12 days depending on the route of infection, the virulence of the strain, and the immune status of the host.
Epidemiology
Fowl cholera has a global distribution and affects a wide range of avian species. Chickens, turkeys, ducks, geese, and game birds such as pheasants and quail are highly susceptible. Turkeys are particularly vulnerable, often experiencing higher mortality rates compared with chickens. Outbreaks are most common in conditions of high stocking density, poor ventilation, inadequate biosecurity, and concurrent infections that compromise host immunity.
The term "fowl cholera meaning in bengali" translates to "মুরগির কলেরা" (murgir kolera), though the disease bears no relation to human cholera caused by Vibrio cholerae. The Bengali nomenclature is used in regional veterinary literature to describe the clinical syndrome in poultry.
In broiler flocks, fowl cholera in broilers manifests as acute septicemia with sudden death. Broilers raised on deep litter systems are at increased risk due to environmental contamination with P. multocida. Flock mortality can range from 10% to 50% in untreated outbreaks. Stressors such as transportation, feed changes, vaccination, and adverse weather conditions often precede clinical outbreaks.
Clinical Signs
The clinical presentation of fowl cholera varies with the disease course, which is classified as peracute, acute, or chronic.
Peracute Form
The peracute form is characterized by sudden death in apparently healthy birds. Mortality spikes rapidly over 12 to 24 hours. Affected birds may be found dead in sternal recumbency with no premonitory signs. This form is most common in highly susceptible species such as turkeys and in outbreaks caused by highly virulent P. multocida strains.
Acute Form
Acute fowl cholera typically presents with fever, depression, anorexia, polydipsia, and a drop in egg production in layers. Respiratory signs include serous to mucoid nasal discharge, rales, dyspnea, and cyanosis of the comb and wattles. Diarrhea is common; the feces may be watery, greenish, or tinged with blood. Swelling and edema of the wattles, infraorbital sinuses, and facial tissues occur due to localized bacterial proliferation and inflammatory exudate. Birds may exhibit lameness due to synovitis or arthritis. Mortality in untreated acute outbreaks often reaches 20% to 50%.
Chronic Form
Chronic fowl cholera develops in birds that survive the acute phase or in flocks infected with less virulent strains. Chronic disease is characterized by localized infections including swollen wattles (wattle edema), conjunctivitis, sinusitis, torticollis due to otitis media or meningitis, dyspnea from airsacculitis, and lameness from arthritis or osteomyelitis. Egg production remains depressed, and affected birds become emaciated over time. The chronic form may persist in a flock for weeks to months, with intermittent shedding of P. multocida perpetuating environmental contamination.
In fowl cholera in broilers, the acute and peracute forms predominate due to the rapid turnover and high stocking density of modern broiler production. Clinical signs in broiler flocks may be noticed first as an increase in daily mortality, with affected birds showing reluctance to move, ruffled feathers, and respiratory distress.
Pathology
Gross Lesions
At necropsy, acute fowl cholera presents with generalized septicemic lesions. Petechial and ecchymotic hemorrhages are observed on the epicardium, serosal surfaces of the viscera, and on the abdominal fat. The liver is enlarged, friable, and tan-colored, with multiple small foci of necrosis (miliary necrosis). The spleen is enlarged and congested. The lungs may be congested and edematous. The kidneys are swollen and pale. The small intestine shows catarrhal enteritis and hemorrhagic foci.
Chronic cases exhibit localized lesions. Wattle edema presents as firm, fluctuant swellings filled with fibrinopurulent exudate. Caseous exudate may be found in the infraorbital sinuses, conjunctival sacs, and middle ear cavities. Arthritis and tenosynovitis are characterized by thickened joint capsules and purulent joint exudate. Oophoritis and peritonitis may be observed in layer hens.
Histopathology
Microscopic examination of liver sections reveals multifocal coagulative necrosis and infiltration of heterophils, macrophages, and fibrin. Gram-negative coccobacilli are visible within tissue sections using Gram stain or Giemsa stain. Acute splenitis, epicarditis, and interstitial pneumonia are consistent findings. In chronic cases, the wattle lesion consists of fibrinonecrotic cellulitis with large numbers of P. multocida organisms.
Diagnosis
Definitive diagnosis of fowl cholera requires isolation and identification of P. multocida from clinical specimens. Tentative diagnosis can be made based on history, clinical signs, and gross pathology.
Sample Collection
Samples should be collected from acutely affected or freshly dead birds. Suitable specimens include heart blood, liver, spleen, lung, bone marrow, and the exudate from swollen wattles or joints. For chronic cases, swabs from sinuses, middle ear, or joint cavities should be submitted.
Isolation and Identification
P. multocida grows readily on blood agar and MacConkey agar (though it does not grow on MacConkey agar for most strains). Colonies on blood agar are small, gray, mucoid, and nonhemolytic. The organism is oxidase positive, catalase positive, indole positive, and does not grow on MacConkey agar (a differentiating feature from Escherichia coli). Bipolar staining with methylene blue is a rapid presumptive identification technique.
Molecular diagnostics such as polymerase chain reaction (PCR) targeting specific P. multocida genes (e.g., kmT1) enable sensitive and specific detection from tissue samples. PCR-based capsular typing and multilocus sequence typing (MLST) are used for epidemiological characterization.
Serotyping
Serotyping is performed using a gel diffusion precipitin test for somatic antigens and a passive hemagglutination test for capsular antigens. Knowledge of the serotype is valuable for vaccine formulation and for tracing outbreak sources.
Differential Diagnosis
Fowl cholera must be differentiated from other causes of acute septicemia in poultry. Key differentials include highly pathogenic avian influenza, Newcastle disease, fowl typhoid (Salmonella Gallinarum), pullorum disease (Salmonella Pullorum), avian colibacillosis, and acute coccidiosis. Respiratory forms of fowl cholera should be differentiated from infectious coryza (Avibacterium paragallinarum), avian mycoplasmosis, and turkey coryza (Bordetella avium). Chronic fowl cholera with wattle edema must be distinguished from mycobacterial infections and tumors.
Treatment
Antimicrobial therapy is the primary treatment for fowl cholera in commercial flocks. However, treatment efficacy depends on the susceptibility profile of the infecting P. multocida strain, which should be determined by broth microdilution or disk diffusion testing.
Antimicrobials commonly used for fowl cholera include tetracyclines (oxytetracycline, chlortetracycline), sulfonamides (sulfadimethoxine, sulfaquinoxaline), penicillin, ampicillin, ceftiofur, enrofloxacin, and florfenicol. Water-soluble formulations are preferred for mass medication. Treatment should be administered for a minimum of 5 to 7 days to prevent relapse. In acute outbreaks, parenteral administration of a fast-acting antibiotic in individual birds may be necessary, though this is impractical in large flocks.
Antimicrobial resistance in P. multocida is an emerging concern. Resistance to tetracyclines, sulfonamides, and beta-lactam antibiotics has been reported. Responsible antimicrobial stewardship, including culture and sensitivity testing prior to treatment, is essential to preserve therapeutic efficacy.
Control and Prevention
Control of fowl cholera relies on a comprehensive program combining biosecurity, management, and vaccination.
Biosecurity
Strict biosecurity measures are critical to prevent the introduction and spread of P. multocida. All-in/all-out production systems, cleaning and disinfection of houses between flocks, and rodent and pest control reduce the environmental burden of the organism. Rodents, particularly rats, can act as mechanical vectors. Access to poultry houses should be restricted, and footbaths with disinfectant should be used at entry points. Contaminated water sources should be chlorinated or replaced.
Control programs for fowl cholera should also address other bacterial respiratory diseases such as Avian Colibacillosis: Etiology, Clinical Signs, and Control of Escherichia coli Infections in Poultry and Infectious Coryza in Poultry: Clinical Signs and Post-Mortem Lesions, as co-infections exacerbate disease severity.
Vaccination
Vaccination is an important tool for reducing the incidence and severity of fowl cholera in endemic regions. Two main types of vaccines are available: inactivated (bacterin) vaccines and live attenuated vaccines.
Inactivated vaccines provide serotype-specific immunity and are typically administered subcutaneously or intramuscularly. They require two initial doses given 2 to 4 weeks apart, followed by boosters every 3 to 6 months. Inactivated vaccines reduce mortality but may not prevent infection or shedding.
Live attenuated vaccines, such as the CU strain (a cho mutant strain), can be administered via drinking water or aerosol. Live vaccines stimulate both humoral and cell-mediated immunity and provide broader cross-protection against heterologous serotypes. They are contraindicated in flocks that are immunocompromised or under antimicrobial therapy.
Vaccination programs should be tailored to the serotypes circulating in the region. Autogenous vaccines prepared from local isolates are sometimes used in persistently affected flocks.
Management
Reducing stress is essential for preventing fowl cholera outbreaks. Adequate ventilation, optimal stocking density, proper nutrition, and control of concurrent diseases (e.g., coccidiosis, mycoplasmosis) enhance host resistance. Prompt removal of sick and dead birds reduces the infectious load in the environment.
Mermaid Diagram: Fowl Cholera Diagnostic and Control Decision Tree
flowchart TD
A[Clinical suspicion: sudden death, respiratory signs, wattle edema], > B[Perform necropsy]
B, > C{Gross lesions consistent with fowl cholera?}
C, >|Yes| D[Collect liver, spleen, heart blood]
C, >|No| E[Consider differential diagnoses]
D, > F[Gram stain & culture on blood agar]
F, > G{Growth of non-hemolytic, oxidase-positive coccobacilli?}
G, >|Yes| H[Confirm by PCR or biochemical tests]
G, >|No| I[Repeat sampling or rule out]
H, > J[Antimicrobial sensitivity testing]
J, > K[Select appropriate antibiotic]
K, > L[Mass medication via water]
L, > M[Implement biosecurity & vaccination]
M, > N[Monitor mortality and clinical response]
N, > O{Response satisfactory?}
O, >|Yes| P[Continue surveillance]
O, >|No| Q[Review sensitivity & adjust treatment]
Q, > K
Conclusion
Fowl cholera is a highly significant bacterial disease of poultry caused by Pasteurella multocida. The disease manifests as peracute, acute, or chronic forms, with acute septicemia and high mortality being the most economically impactful. Diagnosis relies on bacterial isolation, molecular typing, and serotyping. Treatment with appropriate antimicrobials can reduce losses, but antimicrobial resistance necessitates prudent drug use. Long-term control depends on robust biosecurity, stress reduction, and vaccination strategies tailored to local serotypes. A comprehensive understanding of fowl cholera etiology and epidemiology is essential for effective flock management and disease prevention.
References
- Glisson JR, Hofacre CL, Christensen JP. Fowl cholera. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Hoboken: Wiley-Blackwell; 2020. p. 831-862.
- Christensen JP, Bisgaard M. Fowl cholera. In: Saif YM, editor. Diseases of Poultry. 12th ed. Ames: Blackwell Publishing; 2008. p. 762-779.
- Boyce JD, Harper M, Wilkie I, Adler B. Pasteurella multocida. In: Gyles CL, Prescott JF, Songer JG, Thoen CO, editors. Pathogenesis of Bacterial Infections in Animals. 4th ed. Ames: Wiley-Blackwell; 2010. p. 325-346.
- Wilkie IW, Harper M, Boyce JD, Adler B. Pasteurella multocida: diseases and pathogenesis. In: Aktories K, Orth JHC, Adler B, editors. Pasteurella multocida: Molecular Biology, Toxins and Infection. Berlin: Springer; 2012. p. 1-22.
- Merck & Co. Fowl Cholera. In: The Merck Veterinary Manual. 11th ed. Kenilworth: Merck & Co.; 2016.
- Shivaprasad HL. Pathology of fowl cholera. In: Glisson JR, Hofacre CL, Christensen JP, editors. Diseases of Poultry. 14th ed. Hoboken: Wiley-Blackwell; 2020. p. 862-867.
Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.